These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 29185803

  • 1. Better Tolerance of Citalopram in a Breastfed Infant Who Could Not Tolerate Sertraline and Paroxetine.
    Uguz F.
    Breastfeed Med; 2018; 13(1):89-90. PubMed ID: 29185803
    [Abstract] [Full Text] [Related]

  • 2. [The transfer of selective serotonin reuptake inhibitors to human milk].
    Nordeng H, Bergsholm YK, Bøhler E, Spigset O.
    Tidsskr Nor Laegeforen; 2001 Jan 20; 121(2):199-203. PubMed ID: 11475200
    [Abstract] [Full Text] [Related]

  • 3. Short-Term Safety of Paroxetine Plus Low-Dose Mirtazapine During Lactation.
    Uguz F.
    Breastfeed Med; 2019 Mar 20; 14(2):131-132. PubMed ID: 30489153
    [Abstract] [Full Text] [Related]

  • 4. Short-Term Safety of Paroxetine and Sertraline in Breastfed Infants: A Retrospective Cohort Study from a University Hospital.
    Uguz F, Arpaci N.
    Breastfeed Med; 2016 Nov 20; 11():487-489. PubMed ID: 27575664
    [Abstract] [Full Text] [Related]

  • 5. Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: infant exposure, clinical symptoms, and cytochrome p450 genotypes.
    Berle JØ, Steen VM, Aamo TO, Breilid H, Zahlsen K, Spigset O.
    J Clin Psychiatry; 2004 Sep 20; 65(9):1228-34. PubMed ID: 15367050
    [Abstract] [Full Text] [Related]

  • 6. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
    Miner CM, Brown EB, Gonzales JS, Munir R.
    J Clin Psychiatry; 2002 Mar 20; 63(3):232-40. PubMed ID: 11926723
    [Abstract] [Full Text] [Related]

  • 7. Use of contemporary antidepressants during breastfeeding: a proposal for a specific safety index.
    Gentile S.
    Drug Saf; 2007 Mar 20; 30(2):107-21. PubMed ID: 17253877
    [Abstract] [Full Text] [Related]

  • 8. Antidepressant medication use during breastfeeding.
    Lanza di Scalea T, Wisner KL.
    Clin Obstet Gynecol; 2009 Sep 20; 52(3):483-97. PubMed ID: 19661763
    [Abstract] [Full Text] [Related]

  • 9. Incidence of early anxiety aggravation in trials of selective serotonin reuptake inhibitors in depression.
    Näslund J, Hieronymus F, Emilsson JF, Lisinski A, Nilsson S, Eriksson E.
    Acta Psychiatr Scand; 2017 Oct 20; 136(4):343-351. PubMed ID: 28859218
    [Abstract] [Full Text] [Related]

  • 10. Use of sertraline, paroxetine and fluvoxamine by nursing women.
    Hendrick V, Fukuchi A, Altshuler L, Widawski M, Wertheimer A, Brunhuber MV.
    Br J Psychiatry; 2001 Aug 20; 179():163-6. PubMed ID: 11483479
    [Abstract] [Full Text] [Related]

  • 11. Serotonin reuptake inhibitors and breastfeeding: a systematic review.
    Orsolini L, Bellantuono C.
    Hum Psychopharmacol; 2015 Jan 20; 30(1):4-20. PubMed ID: 25572308
    [Abstract] [Full Text] [Related]

  • 12. Citalopram and breast-feeding: serum concentration and side effects in the infant.
    Schmidt K, Olesen OV, Jensen PN.
    Biol Psychiatry; 2000 Jan 15; 47(2):164-5. PubMed ID: 10664835
    [Abstract] [Full Text] [Related]

  • 13. Antidepressant Medication Use During Lactation: A Review for Providers.
    Reuter A, Nerland A, Pritchett D, Skorey M.
    S D Med; 2024 Apr 15; 77(4):172-179. PubMed ID: 38991162
    [Abstract] [Full Text] [Related]

  • 14. Sertraline, citalopram and paroxetine in lactation: passage into breastmilk and infant exposure.
    Den Besten-Bertholee D, Touw DJ, Damer EA, Mian P, Ter Horst PGJ.
    Front Pharmacol; 2024 Apr 15; 15():1414677. PubMed ID: 38841362
    [Abstract] [Full Text] [Related]

  • 15. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.
    Epperson CN, Jatlow PI, Czarkowski K, Anderson GM.
    Pediatrics; 2003 Nov 15; 112(5):e425. PubMed ID: 14595087
    [Abstract] [Full Text] [Related]

  • 16. Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs.
    Epperson N, Czarkowski KA, Ward-O'Brien D, Weiss E, Gueorguieva R, Jatlow P, Anderson GM.
    Am J Psychiatry; 2001 Oct 15; 158(10):1631-7. PubMed ID: 11578995
    [Abstract] [Full Text] [Related]

  • 17. Differential Associations of Specific Selective Serotonin Reuptake Inhibitors With Resting-State Heart Rate and Heart Rate Variability: Implications for Health and Well-Being.
    Kemp AH, Fráguas R, Brunoni AR, Bittencourt MS, Nunes MA, Dantas EM, Andreão RV, Mill JG, Ribeiro AL, Koenig J, Thayer JF, Benseñor IM, Lotufo PA.
    Psychosom Med; 2016 Sep 15; 78(7):810-8. PubMed ID: 27219492
    [Abstract] [Full Text] [Related]

  • 18. Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram.
    Mullins CD, Shaya FT, Meng F, Wang J, Harrison D.
    Pharmacotherapy; 2005 May 15; 25(5):660-7. PubMed ID: 15899727
    [Abstract] [Full Text] [Related]

  • 19. Gastrointestinal Side Effects in the Baby of a Breastfeeding Woman Treated with Low-Dose Fluvoxamine.
    Uguz F.
    J Hum Lact; 2015 Aug 15; 31(3):371-3. PubMed ID: 25896469
    [Abstract] [Full Text] [Related]

  • 20. What are the risks associated with different Selective Serotonin Re-uptake Inhibitors (SSRIs) to treat depression and anxiety in pregnancy? An evaluation of current evidence.
    Womersley K, Ripullone K, Agius M.
    Psychiatr Danub; 2017 Sep 15; 29(Suppl 3):629-644. PubMed ID: 28953843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.